Milton C. Ault III - 23 Jan 2024 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
23 Jan 2024
Net transactions value
$0
Form type
4
Filing time
25 Jan 2024, 17:20:14 UTC
Previous filing
09 Jan 2024
Next filing
02 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Other $0 -661,168 -99% $0.000000 5,498 23 Jan 2024 By Ault Life Sciences Fund, LLC F1, F2
holding ALZN Common Stock 768,365 23 Jan 2024 By Ault Lending, LLC F3
holding ALZN Common Stock 166,865 23 Jan 2024 Direct
holding ALZN Common Stock 996,197 23 Jan 2024 By Ault Life Sciences, Inc. F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Warrants Other $0 -666,666 -100% $0.000000* 0 23 Jan 2024 Common Stock 666,666 $45.00 By Ault Life Sciences Fund, LLC F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares, which were pledged as security for the repayment of a promissory note owed by Ault Life Sciences Fund, LLC ("ALSF"), were returned to the Issuer as part of a settlement agreement between the Issuer and ALSF (the "Settlement Agreement"), whereby the outstanding obligation, among other rights, were terminated.
F2 Mr. Ault has sole voting and investment power with respect to the securities held of record by ALSF.
F3 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F5 These warrants were returned to the Issuer as part of the Settlement Agreement.